Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine
- 16 September 1972
- Vol. 3 (5828), 669-672
- https://doi.org/10.1136/bmj.3.5828.669
Abstract
In five patients with inappropriate lactation and amenorrhoea or impotence brom-ergocryptine was found to suppress the lactation and to diminish the raised plasma prolactin levels. The responses to treatment suggest that there may be an inverse relationship between prolactin secretion and gonadotrophin secretion in man.This publication has 21 references indexed in Scilit:
- Levodopa Suppression of Prolactin in Nonpuerperal GalactorrheaThe New England Journal of Medicine, 1971
- Treatment of Non-puerperal Galactorrhoea with an Ergot AlkaloidBMJ, 1971
- Plasma Prolactin Activity in Inappropriate LactationBMJ, 1971
- THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TESTThe Lancet, 1971
- Pituitary Portal Vessel Infusion of Hypothalamic Extract and Release of LH, FSH and Prolactin1Endocrinology, 1971
- Effects of Melatonin and Serotonin on the Release of FSH and ProlactinEndocrinology, 1971
- Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)Cellular and Molecular Life Sciences, 1971
- [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].1971
- Effects of ergocornine and 2-Br-α-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in miceCellular and Molecular Life Sciences, 1970
- 2-Br-α-Ergokryptin: Beeinflussung von Fertilität und Laktation bei der RatteCellular and Molecular Life Sciences, 1968